Performance, transparency, trust

We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page.

Investors

Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site. 

Read our latest regulatory news

Observe Medical ASA: Q4 2019 financial results

Oslo, 25 February 2020 – Observe Medical ASA (OSE: OBSERV) continued implementation of its growth strategy in the fourth quarter of 2019, including the commercialization of its first product Sippi®. “In the fourth quarter of 2019, we have taken important steps in the commercialization of Sippi. In parallel we have strengthened our foundation for value…

Read more

Reports and presentations

Carve-out financial statements full year 2016-2018 Observe Medical Group

Financial calendar

  • 17.04.20

    Annual Report

  • 12.05.20

    Quarterly Presentation – Q1

  • 03.06.20

    Annual General Meeting

  • 18.08.20

    Half-yearly Report

  • 03.11.20

    Quarterly Presentation – Q3

The Share

Share performance

Shareholders

Last updated 19 february 2020

NameNumber of shares% of top 20% of totalCountry
1 NAVAMEDIC ASA3 200 000 24,86%20,86%Norway
2INGERØ REITEN INV. COMPANY AS2 916 667 22,66%19,01%Norway
3UBS SWITZERLAND AG1 420 522 11,04%9,26%Switzerland
4RO, LARS1 320 231 10,26%8,60%Norway
5ALPINE CAPITAL AS655 9645,10%4,28%Norway
6ARTAL AS489 3413,80%3,19%Norway
7SOLEGLAD INVEST AS ¹416 668 3,24%2,72%Norway
8LEIKERANE AS ²416 666 3,24%2,72%Norway
8TRANBERGKOLLEN INVEST AS ³416 666 3,24%2,72%Norway
10LAPAS AS266 000 2,07%1,73%Norway
11LID, OLAV TARJEI HIORTH250 000 1,94%1,63%Norway
12KRAEBER VERWALTUNG GMBH214 850 1,67%1,40%Germany
13BUKKEVIK INVESTERING AS199 8981,55%1,30%Norway
14ANDREASSEN, KATHRINE E. GAMBORG ¹125 000 0,97%0,81%Norway
15NOBELSYSTEM SCANDINAVIA AS124 3330,97%0,81%Norway
16HARDING INVEST AS101 4380,79%0,66%Norway
17MP PENSJON PK100 025 0,78%0,65%Norway
18EILERAAS, KARL ANSKAR86 491 0,67%0,56%Norway
19BRATVEDT, ASTRID J. TORGERSEN ³77 000 0,60%0,50%Norway
20ERIKSEN, OLE HENRIK ²75 000 0,58%0,50%Norway
Total numer owned by top 2012 872 760100,00%83,90%
Total number of shares15 342 673

¹) Soleglad Invest AS is owned 100% of Kathrine E. Gamborg Andreassen
²) Leikerane AS is owned 100% of Ole Henrik Eriksen
³) Tranbergkollen Invest AS is owned 100% of Astrid J. Torgersen Bratvedt

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Oslo Axess

OBSERV

4 November 2019

Healthcare

NOK

NO0010865009

15 342 673

NOK 0.26

 

Governance

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bernt Olav Røttingsnes (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these. 

For nomination committee please contact: 

Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com

 

IR contact

Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com

Per Arne Nygård, Chief Financial Officer
+47 41 10 43 45 / perarne.nygard@observemedical.com

Sign up for the mailing list